Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms

Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms

Abstract We assessed the real-world effectiveness of sacubitril/valsartan in patients with chronic heart failure (HF) and reduced ejection fraction (HFrEF) with an emphasis on those with older age (≥ 75 years) or with New York Heart Association (NYHA) class IV, for whom greater uncertainty existed r...

Full description

Bibliographic Details
Main Authors: Eléonore Maury, Ann Belmans, Kris Bogaerts, Stefaan Vancayzeele, Mieke Jansen
Format: Article
Language:English
Published: Nature Portfolio 2024-06-01
Series:Scientific Reports
Subjects:
Chronic heart failure
Registry
Real-world
Long-term observational study
Electronic healthcare datasets
Sacubitril/valsartan
Online Access:https://doi.org/10.1038/s41598-024-64243-w

Internet

https://doi.org/10.1038/s41598-024-64243-w

Similar Items